MaineHealth, the state s largest health care system, will use a $12.8 million federal grant to support clinical research aimed at reducing health disparities among people in rural areas.
The funding for MaineHealth s Maine Medical Center Research Institute is a five-year Centers of Biomedical Research Excellence grant from the National Institutes of Health in Washington, D.C., according to a news release Wednesday.
MaineHealth said the funding will be used to develop a statewide research and care network in the state, addressing barriers associated with limited resources, expertise and access in rural areas. The project will begin with support of four clinical studies.
MaineHealth receives $12.8 million grant for rural health care research
It will use the funds, from the National Institutes of Health, to study ways to reduce the disparity in health care quality between urban and rural areas of the state.
Staff Report
Share
MaineHealth plans to use a five-year, $12.8 million Centers of Biomedical Research Excellence, or COBRE, grant from the National Institutes of Health to study ways to reduce the disparity in health care quality between urban and rural areas of the state.
The state’s largest health care system said the funding will be used by the Maine Medical Center Research Institute to support clinical research aimed at reducing rural health disparities in acute care settings such as emergency rooms.
MaineHealth receives $12 8 million grant for rural health care research sunjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sunjournal.com Daily Mail and Mail on Sunday newspapers.
Letter to the editor: Most vulnerable Mainers pushed aside
A volunteer vaccinator at MMC reports administering the COVID vaccine to MaineHealth employees while many people in much greater need still have no access.
Share
As a volunteer vaccinator at Maine Medical Center, I believe that MaineHealth CEO Bill Caron should be ashamed of himself for going against state guidelines in his decision to vaccinate young employees who have no face-to-face contact with patients.
At recent clinics I have vaccinated MaineHealth grant writers, research scientists from the Maine Medical Center Research Institute and medical records employees working from home. None of them was over 70 years old. Meanwhile, my wife’s 94-year-old father, living independently, was unvaccinated until very recently. Elderly patients of private-practice physicians remain unvaccinated. Rural Maine remains largely unvaccinated. What’s wrong with this picture?
Could this diabetes drug be a game changer for weight loss?
Semaglutide, a
Novo Nordisk drug that s currently approved to treat Type 2 diabetes, appeared to help obese patients lose an average of 15% of their body weight when paired with dietary and lifestyle changes, according to trial results published in the
New England Journal of Medicine (NEJM) but some experts say the trial contained notable limitations.
For the trial, researchers at
Northwestern University enrolled 1,961 adults who had a body mass index (BMI) of at least 30, or a BMI of at least 27 with at least one coexisting condition related to their weight that was not Type 2 diabetes. The trial took place at 129 centers across 16 countries, and it involved participants self-injecting either semaglutide or a placebo once each week for 68 weeks. The trial was blinded, so participants do not know whether they were self-administering semaglutide or a placebo. During the study period, participants also received indi